Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age
Clinical trial NCT01209780 · COMPLETED
Trial details
- NCT number
- NCT01209780
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-03-01
- Enrollment
- 3116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.